Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Motor Activity 3 Head and Neck Neoplasms 3 Breast Neoplasms 3 Pharyngeal Neoplasms 2 Obesity 2 Laryngeal Neoplasms 2 Diabetes Mellitus, Type 2 2 Colonic Neoplasms 2 Weight Loss 1 Sarcopenia 1 Lung Neoplasms 1 Lung Diseases 1 Liver Neoplasms 1 Liver Diseases 1 Gastrointestinal Neoplasms 1 Chronic Disease 1 COVID-19 1 Brain Neoplasms 1 Body Weight Changes 1

Interventions

Temozolomide 94 Radiotherapy 59 Bevacizumab 59 Radiosurgery 41 Carboplatin 27 Irinotecan 26 Magnetic Resonance Spectroscopy 25 Surgical Procedures, Operative 23 Etoposide 22 Carmustine 20 Filgrastim 18 Erlotinib Hydrochloride 17 Cyclophosphamide 16 Cisplatin 16 Vincristine 15 Lomustine 15 Lapatinib 15 Sorafenib 13 Radiation 13 Trastuzumab 12 Nivolumab 12 Imatinib Mesylate 12 Thalidomide 11 Surveys and Questionnaires 11 Granulocyte Colony-Stimulating Factor 11 Radiotherapy, Intensity-Modulated 10 Aminolevulinic Acid 10 temsirolimus 9 Topotecan 9 Thiotepa 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Brain Neoplasms × Nutritional Status × Clear all

NCT01770626 2014-10-28

BEAM

University of Alabama at Birmingham

Phase EARLY_PHASE1 Completed

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡